ArticleChronic diseases and translational medicine2026
Clinical Efficacy of Periosteum-Preserving Iliac Crest Transverse Transport for Symptomatic High-Level Lower Extremity Arteriosclerosis Obliterans.
Article in Chronic diseases and translational medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
What's New?: This study introduces a novel, periosteum-preserving iliac crest transverse transport (ICTT) technique for high-level lower extremity arteriosclerosis obliterans (LEASO), targeting patients unsuitable for conventional revascularization.Technical Innovation: By relocating the osteotomy from the weight-bearing tibia to the non-weight-bearing ilium, this minimally invasive technique eliminates the risk of stress fractures, allows for immediate full weight-bearing, and expands indications to patients with proximal arterial occlusions.Clinical Efficacy: The procedure proved highly effective, resulting in significant ischemic pain relief, a measurable increase in distal limb perfusion, and a 100% healing rate for all chronic ulcers and non-healing amputation stumps.Key Finding: ICTT appears to be a safe and potent biological intervention that addresses the critical issue of microvascular dysfunction in LEASO, offering a promising new limb salvage strategy with no major complications observed.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.